Big Pharmas Like Cipla, Pfizer Among the 200 Under Inspection for Poor Drugs

New Delhi: The Drug Controller General of India has launched inspections against 200 drugmakers, including leading firms like Cipla and Pfizer, for allegedly selling poor quality medicines and non-compliance to manufacturing norms.

"We have already inspected 36 drug manufacturing plants over last three months. In the second phase, starting from Monday, we will conduct inspections in 20 more facilities, " an official in the health ministry told TOI.

According to a source, notices have been issued recently to Cipla and Pfizer informing them of the upcoming inspection as well as violations found in their products.

Back to news